RxDoctor Payments DataLook up a doctor →

Liliana Nazario, MD

Family Medicine · Overland Park, KSNPI 1629063557

Payments from drug & device makers

$14,654in general payments, 2019–2025

Across 944 payments — averaging $15.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • AstraZeneca$2K
  • Novo Nordisk$2K
  • Lilly USA, LLC$1K
  • Amgen$1K
  • Pfizer$968
  • plus $6K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)148$2,103
AstraZeneca80$1,762
Novo Nordisk108$1,723
Lilly USA, LLC88$1,323
Amgen(2 entities)72$1,065
Pfizer81$968
Amarin Pharma, Inc.39$531
Boehringer Ingelheim31$491
Antares Pharma, Inc.23$431
GSK24$367
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC24$362
Merck30$333
Astellas Pharma US Inc15$319
Abbott8$238
Johnson & Johnson13$204
Bayer9$189
Takeda Pharmaceuticals U.S.A., Inc.15$188
Biohaven Pharmaceutical Holding Company Ltd.13$185
Kowa Pharmaceuticals America, Inc.13$166
Phathom Pharmaceuticals, Inc.8$117
Biohaven Pharmaceuticals, Inc.6$113
Eisai Inc.7$94
Novartis6$92
Endo Pharmaceuticals Inc.5$71
IBSA Pharma Inc.4$63
Idorsia Pharmaceuticals US Inc3$61
Sumitomo Pharma America, Inc.4$54
Boston Scientific1$52
Currax Pharmaceuticals LLC4$52
Jazz Pharmaceuticals Inc.3$50
Ironshore Pharmaceuticals Inc.3$46
Collegium Pharmaceutical, Inc.3$45
Corium, LLC4$45
Exact Sciences3$44
Amneal Pharmaceuticals LLC3$43
Esperion Therapeutics, Inc.3$40
Sanofi2$38
Sunovion Pharmaceuticals Inc.3$37
Dexcom, Inc.2$36
Axsome Therapeutics, Inc.2$34
Daiichi Sankyo Inc.2$33
Tolmar, Inc.2$32
Noven Therapeutics, LLC2$31
Supernus Pharmaceuticals, Inc.2$30
Aytu Biopharma, Inc.2$28
Hologic Sales And Service, LLC2$26
Nestle Healthcare Nutrition Inc.1$26
Shire North American Group Inc2$26
Clarus Therapeutics Inc.2$24
Globus Medical1$22
Millicent US Inc1$20
Resmed Corp1$20
Dynavax Technologies Corporation1$19
Upsher-smith Laboratories LLC1$19
Lundbeck LLC1$19
Ardelyx, Inc.1$17
Si-bone, Inc.1$17
Otsuka America Pharmaceutical, Inc.1$16
Ultragenyx Pharmaceutical Inc.1$15
Neos Therapeutics, LP1$13

How this compares

$14,654 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$155,520
Medicare patients
358
Services billed
4,158

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Overland Park

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →